A comparative multi-parametric in vitro model identifies the power of test conditions to predict the fibrotic tendency of a biomaterial
Abstract Despite growing effort to advance materials towards a low fibrotic progression, all implants elicit adverse tissue responses. Pre-clinical biomaterial assessment relies on animals testing, which can be complemented by in vitro tests to address the Russell and Burch’s 3R aspect of reducing a...
Guardado en:
Autores principales: | Maren Jannasch, Sabine Gaetzner, Tobias Weigel, Heike Walles, Tobias Schmitz, Jan Hansmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b1d66dde8054436fb98773093d489942 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multi-channel impedance analyzer for automated testing of networks and biomaterials
por: Schmidt Wolfram, et al.
Publicado: (2020) -
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
por: Elena López-Isac, et al.
Publicado: (2019) -
Biomaterials
Publicado: (1980) -
Cellular senescence mediates fibrotic pulmonary disease
por: Marissa J. Schafer, et al.
Publicado: (2017) -
Test conditions can significantly affect the results of in vitro cytotoxicity testing of degradable metallic biomaterials
por: Eva Jablonská, et al.
Publicado: (2021)